Prof. Amal is currently a Visiting Professor at Boston Children's Hospital, Harvard Medical School at Harvard University. Prof. Haitham Amal, is a world-leading expert in nitric oxide and brain disorders. He is the head of The Laboratory of Neuromics, Cell Signaling, and Translational Medicine. His lab leads multidisciplinary research combining OMICS technology with systems biology together with biochemical, pharmacological, and behavioral tools.

 

Prof. Amal conducted his postdoctoral studies at the Massachusetts Institute of Technology (MIT). Prof. Amal was a Senior Postdoctoral Associate at the Biological Engineering Department at MIT and an affiliate in the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard. Prof. Amal has received many awards/grants including the German DFG Grant, the Israel Science Foundation grant, the prestigious Krill Prize administered by the Wolf Foundation, US Department of Defense (DoD) grant, he was listed among the 40 under 40 most promising young people by The Marker Magazine, The Kaye Innovation Award, the Prusiner Abramsky Neuroscience Award, Maof Research Grant, the Golda Meir Lectureship Award, and the MIT-Technion Postdoc Fellowship.

 

Just recently, he won the US Eagles Autism Foundation Research Grant. Professor Amal is the first international scientist to win this prestigious grant!He was the first to show the first link between nitric oxide and autism spectrum disorder (ASD) published in Advanced Science. Almetric (a weighted count of the attention that a scholarly article has received) has tracked ~ 25 million papers and his groundbreaking paper in Advanced Science was in the top 5% of all research outputs ever tracked. The paper was on the news in many languages including Spanish, Chinese, Portuguese, French, Italian, Hebrew, Arabic, and more. One of the other Amal's discoveries showed pathological similarities between ASD and Alzheimer's pathologies both from the genetic and environmental backgrounds.